Literature DB >> 28549211

Chronic sinonasal tract inflammation as a precursor to nasopharyngeal carcinoma and sinonasal malignancy in the United States.

Eric L Wu1, Charles A Riley1, Mei-Chin Hsieh2, Michael J Marino1, Xiao-Cheng Wu2, Edward D McCoul1,3,4.   

Abstract

BACKGROUND: Chronic inflammatory states have been linked to the development of malignancy. Chronic rhinosinusitis (CRS) and allergic rhinitis (AR) have been associated with nasopharyngeal carcinoma (NPC) in population-based studies in Asia. A similar association with NPC and paranasal sinus malignancy (PSM) has not been defined in a North American population. Our purpose was to investigate the impact of CRS and AR on the risk of NPC and PSM.
METHODS: The Surveillance, Epidemiology, and End Results (SEER)-Medicare linked database was queried as a case-control study of adults ≥65 years of age. The study cohort included 2009 patients diagnosed with NPC and/or PSM diagnosed between 2003 and 2011, and 2009 propensity-score-matched controls selected from a 5% random sample of Medicare beneficiaries without cancer. CRS and AR were examined as exposures. Multivariable unconditional logistic regression was employed.
RESULTS: Overall, NPC and PSM patients were more likely to have previous CRS diagnosis than the controls (9.2% vs 3.0% and 11.1% vs 2.7%, respectively). CRS was associated with greater odds of developing NPC (odds ratio [OR], 3.51; 95% confidence interval [CI], 2.12-5.79) and PSM (OR, 5.30; 95% CI, 3.55-7.92). AR was associated with greater odds of developing NPC (OR, 4.23; 95% CI, 2.96 to 6.06) and PSM (OR, 3.35; 95% CI, 2.49-4.49). The number needed to harm in the exposed population was 311.
CONCLUSIONS: CRS and AR are associated with the presence of NPC and PSM in the elderly population of United States. This epidemiologic association will need to be examined for causative pathophysiologic mechanisms and utility in clinical diagnosis.
© 2017 ARS-AAOA, LLC.

Entities:  

Keywords:  allergic rhinitis; chronic rhinosinusitis; nasopharyngeal carcinoma; paranasal sinus malignancy

Mesh:

Year:  2017        PMID: 28549211     DOI: 10.1002/alr.21956

Source DB:  PubMed          Journal:  Int Forum Allergy Rhinol        ISSN: 2042-6976            Impact factor:   3.858


  8 in total

1.  Medical History, Medication Use, and Risk of Nasopharyngeal Carcinoma.

Authors:  Xiling Xiao; Zhe Zhang; Ellen T Chang; Zhiwei Liu; Qing Liu; Yonglin Cai; Guomin Chen; Qi-Hong Huang; Shang-Hang Xie; Su-Mei Cao; Jian-Yong Shao; Wei-Hua Jia; Yuming Zheng; Jian Liao; Yufeng Chen; Longde Lin; Ingemar Ernberg; Guangwu Huang; Yi Zeng; Yi-Xin Zeng; Hans-Olov Adami; Weimin Ye
Journal:  Am J Epidemiol       Date:  2018-10-01       Impact factor: 4.897

Review 2.  Chronic Rhinosinusitis with Nasal Polyps in Older Adults: Clinical Presentation, Pathophysiology, and Comorbidity.

Authors:  Woo-Jung Song; Ji-Hyang Lee; Ha-Kyeong Won; Claus Bachert
Journal:  Curr Allergy Asthma Rep       Date:  2019-09-05       Impact factor: 4.806

3.  Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells.

Authors:  Shuo Li; Xiaomeng Zhang; Rongkai Zhang; Zibin Liang; Wei Liao; Zhengde Du; Chunsheng Gao; Fei Liu; Yunping Fan; Haiyu Hong
Journal:  Cell Cycle       Date:  2017-07-27       Impact factor: 4.534

4.  Diagnostic usefulness of cone-beam computed tomography versus multi-detector computed tomography for sinonasal structure evaluation.

Authors:  Miran Han; Hyun Jun Kim; Jin Wook Choi; Do-Yang Park; Jang Gyu Han
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-03-30

5.  Development and validation of immune inflammation-based index for predicting the clinical outcome in patients with nasopharyngeal carcinoma.

Authors:  Xiaojiao Zeng; Guohong Liu; Yunbao Pan; Yirong Li
Journal:  J Cell Mol Med       Date:  2020-06-30       Impact factor: 5.310

6.  Extramedullary nasal plasmacytoma arising after polyp excision and the role of the inflammation in tumor development: A case report.

Authors:  Arianna Di Stadio; Valeria Gambacorta; Stefano de Crescenzo; Angelo Sidoni; Maria Cristina Cristi; Alfredo Di Giovanni; Massimo Maranzano; Giampietro Ricci
Journal:  Mol Clin Oncol       Date:  2020-02-26

Review 7.  Autoimmunity as an Etiological Factor of Cancer: The Transformative Potential of Chronic Type 2 Inflammation.

Authors:  Chris M Li; Zhibin Chen
Journal:  Front Cell Dev Biol       Date:  2021-06-21

8.  MiR-126 in intestinal-type sinonasal adenocarcinomas: exosomal transfer of MiR-126 promotes anti-tumour responses.

Authors:  Marco Tomasetti; Massimo Re; Federica Monaco; Simona Gaetani; Corrado Rubini; Andrea Bertini; Ernesto Pasquini; Cristiana Bersaglieri; Massimo Bracci; Sara Staffolani; Mariastella Colomba; Armando Gregorini; Matteo Valentino; Adriano Tagliabracci; Massimo Bovenzi; Jiri Neuzil; Monica Amati; Lory Santarelli
Journal:  BMC Cancer       Date:  2018-09-17       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.